The appeal of ingredient-first solutions like GLP-1 Plus lies in the fact that they can be discussed openly without requiring access to medical channels or prescription-only products
Orforglipron is an investigational drug and is still in Phase 3 trials
Takeda is supporting the BLA with data from the pivotal VISIBLE 2 Phase III trial, in which 409 adult patients experienced a clinical responsedefined as a decrease of 70 points or more in Crohns Disease Activity Index (CDAI) score from baselinefollowing two doses of open-label IV Entyvio
Feel Better, Faster From the Inside Out Premium IV treatments designed to support energy, immunity, recovery, and overall wellness
Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development
Fiber and polyphenol-rich plants feed the wider community that Akkermansia cross-feeds, including the butyrate producers described above